As disease management programs have grown in size and scope, the importance of justifying their expense by demonstrating financial savings has become critical.

Unfortunately, healthcare's complex business model, dynamic technology and regulatory changes, and potential for market disruptions render conventional strategic planning processes and financial decision-making tools less effective.

There are incalculable advantages to be gained from the use of clinical data in studying chronic diseases across communities and larger populations.

Hospital medicine groups yield cost savings of approximately 13% while delivering high quality care and patient satisfaction, irrespective of the business model.

If there was a way to accurately and consistently predict which patients were likely to use the emergency room in the upcoming year or incur a preventable chronic disease in the next 10 years, how would such a capability impact patient care?

A successful health information exchange (HIE) must be constructed in a manner that accounts for and serves the needs of each stakeholder group individually and allows all, to share in the benefit. As a result, the success of a community-based HIE is as much a feat of cooperation as it is one of organization.

Major changes are under way in global accounting standards, and all U.S. insurance companies will be affected.

The healthcare industry is calling for greater connectivity, or interoperability standards to increase adoption, safety and implementation.

Specialty pharmacy as a managed benefit has arrived at the same place pharmacy benefit management was several years ago (offering open formularies, flat co-pays, etc.). Yet little is being done to address specialty pharmacy as a managed benefit.